Virtus LifeSci Biotech Cl... (BBC)
NYSEArca: BBC
· 实时价格 · USD
52.39
-2.95 (-5.33%)
收盘价： Aug 31, 2026, 12:09 PM
Virtus LifeSci Biotech Clinical Trials ETF（BBC）ETF 价格、持仓与分析
-5.33% (1D)
| 买价 | 53.25 |
| 市值 | n/a |
| 管理资产规模（AUM） | 46.39M |
| 净值（NAV） | 55.15 |
| 贝塔（Beta） | 1.26 |
| 每股收益（EPS，过去十二个月） | 无 |
| 市盈率（PE，过去十二个月） | 无 |
| 流通股数 | 无 |
| 成立日期 | Dec 16, 2014 |
| 卖价 | 55.37 |
| 成交量 | 18,256 |
| 平均成交量（20日） | 22,720 |
| 开盘价 | 55.56 |
| 前收盘价 | 55.34 |
| 日内区间 | 53.20 - 54.42 |
| 52周区间 | 22.82 - 56.18 |
| 持仓 | 无 |
| 费用率 | 0.65% |
关于BBC
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
前十大持仓 占资产的11.76%
| 名称 | 代码 | 权重 |
|---|---|---|
| First Tracks Biother... | TRAX | 1.67% |
| Mbx Biosciences Inc | MBX | 1.24% |
| Ataibeckley Inc | ATAI | 1.23% |
| Monopar Therapeutics... | MNPR | 1.21% |
| Definium Therapeutic... | DFTX | 1.18% |
| Xencor Inc | XNCR | 1.10% |
| Zenas Biopharma Inc | ZBIO | 1.06% |
| Uniqure Nv | QURE | 1.06% |
| Apogee Therapeutics ... | APGE | 1.02% |
| Vor Biopharma Inc Or... | VOR | 0.99% |
分红 分红收益率 1.25%
| 除息日 | 金额 | 支付日期 |
|---|---|---|
| Dec 22, 2025 | $0.6550 | 无 |
| Dec 20, 2024 | $0.2400 | 无 |
| Dec 20, 2023 | $0.0820 | 无 |
| Dec 20, 2017 | $0.2970 | 无 |
| Dec 21, 2015 | $0.1470 | 无 |
第 1 页，共 2 页